Breast cancer vaccine that elicits powerful immune response also improves recurrence
 

A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

More...

Re: Breast cancer vaccine that elicits powerful immune response also improves recurre
 

WooHoo! SandraGA, more good news in your arm of the trial. I hope my GPII vaccine generates some good news. I have the last booster shots at the beginning of June . . . and a follow up blood draw and I return to life with just some phone calls and emails for 2 1/2 years of follow up.